| Literature DB >> 35894841 |
Chenghui Ke1, Hongyun Li2, Dan Yang1, Hao Ying1, Hongwen Zhu3, Jian Wang4, Jun Xu4, Lin Wang1.
Abstract
OBJECTIVE: To investigate the correlation between melatonin and osteoarthritis (OA) in rats. To explore the relevant mechanisms in the occurrence and development of osteoarthritis in rats, and to further understand the disease of osteoarthritis.Entities:
Keywords: Inflammatory factor; Melatonin antagonist; Osteoarthritis model; Papain; SD male rats
Mesh:
Substances:
Year: 2022 PMID: 35894841 PMCID: PMC9483081 DOI: 10.1111/os.13408
Source DB: PubMed Journal: Orthop Surg ISSN: 1757-7853 Impact factor: 2.279
Fig. 1X‐ray of rats in the sham and melatonin antagonist injection groups before surgery. The whole‐body skeleton of rats in each group was normal before surgery, and no bilateral knee lesions were found in any of the rats, which met the experimental requirements. The parameters were as follows: 41 kV and 2.80 mAs
Fig. 2In the first week of the experiment, MRI of rats before modeling: (A, B) MRI results of the knee joints of rats before modeling; 4 weeks after the beginning of the experiment (C and D) after modeling of knee osteoarthritis of rats MRI results of rat knee joint. Compared with the MRI of the rat knee joint before modeling, it can be seen that the cartilage on the surface of the knee joint was gross; the signal was discontinuous at some levels. The overall structure of the knee joint was intact, with no obvious wear and tear and osteophyte in the subchondral bone
Fig. 3On the 9th week after the start of the experiment, the pathological tissues of the rats in each group after knee osteoarthritis modeling (low power lens: 40 × 10; HE staining). (AL) Left knee joint of the sham group; (A) Right knee joint in the sham group; (B) Right knee joint in the drug intervention group.
Fig. 4On the 9th week after the start of the experiment, the pathological tissues of the rats in each group after knee osteoarthritis modeling (low power lens: 40 × 10; toluidine blue staining). (AL) Left knee joint of the mice in the sham group; (A) Right knee joint of the rats in the sham group with a mild loss of cartilage matrix staining; (B) Drug intervention group with a moderate to a severe loss of cartilage matrix staining.
IL‐6 of rats in each group before and after OA modeling (n = 20, x ± s, pg/ml)
| Groups | Before OA modeling | 2W after OA modeling | 2W after drug intervention | 3W after drug intervention | 4W after drug intervention |
|---|---|---|---|---|---|
| Sham group | 438.8 ± 130.1 | 650.3 ± 124.1 | 828.2 ± 117.1 | 1047.1 ± 140.1 | 1255.6 ± 142.5 |
| Drug intervention group | 430.7 ± 121.8 | 724.8 ± 100.1 | 944.0 ± 106.1 | 1158.1 ± 86.1 | 1391.6 ± 100.7 |
|
| 2.01 | 5.26 | 69.51 | 7.41 | 6.55 |
|
| 0.0012 | 0.004 | 0.058 | 0.003 | 0.002 |
Note: For the between‐group mean comparison, indicating the results are statistically significant; for the within‐group mean comparison between “before OA modeling group” and “2W after OA modeling group”, indicating the results are statistically significant; For the mean comparison between “2W after drug intervention group” and “3W after drug intervention group”, indicating the results are statistically significant;For the mean comparison between “3W after drug intervention group” and “4W after drug intervention group”, indicating the results are statistically significant.
IL‐1β of rats in each group before and after OA modeling (n = 20, x ± s, pg/ml)
| Groups | Before OA modeling | 2W after OA modeling | 2W after drug intervention | 3W after drug intervention | 4W after drug intervention |
|---|---|---|---|---|---|
| Sham group | 167.2 ± 43.2 | 219.4 ± 24.1 | 264.4 ± 42.9 | 308.2 ± 44.7 | 357.2 ± 45.3 |
| Drug intervention group | 169.3 ± 42.2 | 277.2 ± 43.1 | 342.1 ± 106.1 | 392.1 ± 106.1 | 460.2 ± 106.1 |
|
| 4.72 | 8.39 | 38.54 | 7.59 | 4.96 |
|
| 0.002 | 0.001 | 0.058 | 0.0031 | 0.0016 |
Note: For the between‐group mean comparison, indicating the results are statistically significant; For the within‐group mean comparison between “before OA modeling group” and “2W after OA modeling”, indicating the results are statistically significant; For the mean comparison between “2W after drug intervention group” and “3W after drug intervention group”, indicating the results are statistically significant;For the mean comparison between “3W after drug intervention group” and “4W after drug intervention group”, indicating the results are statistically significant.
COX‐2 of rats in each group before and after OA modeling (n = 20, x ± s, U/L)
| Groups | Before OA modeling | 2W after OA modeling | 2W after drug intervention | 3W after drug intervention | 4W after drug intervention |
|---|---|---|---|---|---|
| Sham group | 173.4 ± 12.6 | 213.3 ± 24.1 | 254.7 ± 31.1 | 296.3 ± 31.0 | 335.9 ± 32.3 |
| Drug intervention group | 198.6 ± 20.6 | 264.6 ± 22.1 | 334.4 ± 106.1 | 403.8 ± 106.1 | 474.6 ± 106.1 |
|
| 9.77 | 7.22 | 49.77 | 8.51 | 3.96 |
|
| 0.002 | 0.0013 | 0.058 | 0.0018 | 0.0011 |
Note: For the between‐group mean comparison, indicating the results are statistically significant; For the within‐group mean comparison between before OA modeling group and 2W after OA modeling, indicating the results are statistically significant; For the mean comparison between 2W after drug intervention group and 3W after drug intervention group, indicating the results are statistically significant; For the mean comparison between 3W after drug intervention group and 4W after drug intervention group, indicating the results are statistically significant.
Melatonin of each group at different periods before and after OA modeling
| Groups | Before OA modeling | 2W after drug intervention |
|---|---|---|
| Sham group | 221.62 ± 26.48 | 268.20 ± 23.87 |
| Drug intervention group | 268.20 ± 23.87 | 117.48 ± 29.07 |
|
| 7.22 | 5.84 |
|
| 0.0012 | 0.001 |
Note: For the between‐group mean comparison at the same period, indicating the results are statistically significant; for the within‐group mean comparison, indicating the results are statistically significant.